<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>23</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Methylprednisolone-Induced Hyperlactatemia: A Case Report</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>409</FirstPage>
			<LastPage>412</LastPage>
			<ELocationID EIdType="pii">728976</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sarah</FirstName>
					<LastName>Saenz</LastName>
<Affiliation>Department of Anesthesiology, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0009-0009-8479-4373</Identifier>

</Author>
<Author>
					<FirstName>Anila</FirstName>
					<LastName>Bhatti</LastName>
<Affiliation>Department of Anesthesiology, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0009-0008-5471-6123</Identifier>

</Author>
<Author>
					<FirstName>Aaron</FirstName>
					<LastName>Beck</LastName>
<Affiliation>Department of Orthopedic Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-4847-6900</Identifier>

</Author>
<Author>
					<FirstName>Micah T.</FirstName>
					<LastName>Long</LastName>
<Affiliation>Department of Anesthesiology, University of Wisconsin Hospital and Clinics, Madison, WI, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-7297-5304</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>07</Month>
					<Day>23</Day>
				</PubDate>
			</History>
		<Abstract>Lactic acidosis is commonly encountered in critical care and can be a harbinger of life-threatening conditions and end-organ ischemia. Importantly, however, other etiologies of lactic acidosis exist. We review the first case of methylprednisolone-induced lactic acidosis in a previously healthy patient who suffered from traumatic spinal cord injury (SCI). A 19-year-old female presented to a level 1 trauma center after a fall resulted in lower extremity paralysis. After imaging revealed a chance fracture dislocation of T7-8 along with spinal cord compromise and swelling, the patient underwent emergent T5-T11 instrumented fusion. Postoperatively, she was given high-dose methylprednisolone in hopes of improving neurologic outcome; soon after administration, she developed lactic acidosis. After workup ruled out hypoperfusion and type A lactic acidosis, we determined that methylprednisolone likely induced non-ischemic, type B, lactic acidosis. The lactate quickly returned to baseline after steroid discontinuation. It is important for clinicians to consider type B lactic acidosis in the ICU in patients with persistent lactic acidosis after tissue hypoperfusion has been ruled out.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Resuscitation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lactic acidosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Steroids</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Spinal Cord Injury</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_728976_d87bce0e6d18c90bedcbdd275258bf3c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
